Porkert, S. (2021) “Long-term Therapeutic Success of Intravenous Rituximab in 26 Patients with Indolent Primary Cutaneous B-cell Lymphoma”, Acta Dermato-Venereologica, 101(2), p. adv00383. doi: 10.2340/00015555-3746.